ADRA2A and schizophrenia: The unique upregulation of ADRA2A mRNA expression in AP-treated schizophrenia subjects but not in AP-treated rats is likely an outcome of epigenetic predisposition depicted by enhanced bivalent chromatin at ADRA2A promoter.